BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16012009)

  • 1. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
    Engel PM; Dennin RH
    Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.
    Bresters D; Zaaijer HL; Cuypers HT; Reesink HW; Winkel IN; van Exel-Oehlers PJ; van Drimmelen AA; Jansen PL; van der Poel CL; Lelie PN
    Transfusion; 1993 Aug; 33(8):634-8. PubMed ID: 7688158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus.
    Damen M; Zaaijer HL; Cuypers HT; Vrielink H; van der Poel CL; Reesink HW; Lelie PN
    Transfusion; 1995 Sep; 35(9):745-9. PubMed ID: 7570934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
    Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
    J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.
    Piro L; Solinas S; Luciani M; Casale A; Bighiani T; Santonocito D; Girelli G
    Blood Transfus; 2008 Apr; 6(2):107-11. PubMed ID: 18946955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
    Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
    J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
    Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
    Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.
    Kiely P; Kay D; Parker S; Piscitelli L
    Transfusion; 2004 Mar; 44(3):349-58. PubMed ID: 14996191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
    Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
    Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay.
    Pawlotsky JM; Bastie A; Pellet C; Remire J; Darthuy F; Wolfe L; Sayada C; Duval J; Dhumeaux D
    J Clin Microbiol; 1996 Jan; 34(1):80-3. PubMed ID: 8748278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indeterminate results of the second-generation hepatitis C virus (HCV) recombinant immunoblot assay: significance of high-level c22-3 reactivity and influence of HCV genotypes.
    Zein NN; Germer JJ; Wendt NK; Schimek CM; Thorvilson JN; Mitchell PS; Persing DH
    J Clin Microbiol; 1997 Jan; 35(1):311-2. PubMed ID: 8968936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
    Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
    J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
    Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
    J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV.
    Cribier B; Rey D; Schmitt C; Lang JM; Kirn A; Stoll-Keller F
    AIDS; 1995 Oct; 9(10):1131-6. PubMed ID: 8519448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the persistence and characteristics of indeterminate reactivity against hepatitis C virus in blood donors.
    Melve GK; Myrmel H; Eide GE; Hervig T
    Transfusion; 2009 Nov; 49(11):2359-65. PubMed ID: 19702654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.